Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing’s Sarcoma to an Inhibitor of Glutamine Metabolism

Open Access

Peer-reviewed

Research Article

Rachelle R. Olsen,

Affiliation Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America
⨯
Michelle N. Mary-Sinclair,

Affiliation Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America
⨯
Zhirong Yin,

Affiliation Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America
⨯
Kevin W. Freeman

* E-mail: kevin.freeman@stjude.org

Affiliation Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America
⨯

Reader Comments (0)

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Glutamine
Is the Subject Area "Glutamine" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Amino acid metabolism
Is the Subject Area "Amino acid metabolism" applicable to this article?

Thanks for your feedback.
Ewing sarcoma
Is the Subject Area "Ewing sarcoma" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Cell metabolism
Is the Subject Area "Cell metabolism" applicable to this article?

Thanks for your feedback.